Peer-influenced content. Sources you trust. No registration required. This is HCN.
OBR Oncology
Learn about a ground-breaking strategy for treating uncommon brain tumors like papillary craniopharyngiomas (PCPs), where precision medicine and BRAF/MEK inhibitors marked a major improvement in brain cancer treatment by drastically reducing tumor size.
Neurology July 18th 2023
Epilepsy Currents
Unravel the intricacies of the shifting cost and usage trends of first-line treatments for IESS, and join the conversation about the future of managing this condition.
Neurology July 11th 2023
ALS News Today
Scientists at the Harvard T.H. Chan School of Public Health are looking at the role of alpha-linolenic acid in ALS management, as their research links high blood levels of this omega-3 fatty acid to slower disease progression and longer survival in patients.
Multiple Sclerosis News Today
Gadoquatrane, a promising GBCA, enters Phase 3 clinical testing, potentially offering safer MRI procedures and advancing diagnostic capabilities for patients with CNS disorders, including MS.
MDLinx
The surprising association between CHIP and a lowered risk of Alzheimer’s disease offers a novel perspective in our understanding of neurodegenerative disorders and paves the way for potential future therapeutics.
Hematology July 11th 2023
British Medical Journal
Emerging research uncovers potential associations between the use of menopausal hormone therapy and an increased risk of dementia, including Alzheimer’s disease. Discover more about the implications of these findings for women’s health management.